Antiretroviral kombinationsbehandling er blevet associeret med metaboliske abnormaliteter så som hypertriglyceridæmi, hyperkolesterolæmi, insulinresistens, hyperglykæmi og hyperlaktæmi (se pkt.
Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactaemia.